Selected publications
-
Phase I study of inhaled doxorubicin for patients with metastatic tumors to the lungs.
Clinical Cancer Research.
2007
Academic Article
GET IT
Times cited: 68 -
TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
Journal of Clinical Oncology.
2005
Academic Article
GET IT
Times cited: 1266 -
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial.
JAMA - Journal of the American Medical Association.
2003
Academic Article
GET IT
Times cited: 2250 -
Pilot trial of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib plus carboplatin and paclitaxel in patients with stage IIIB or IV non-small-cell lung cancer.
Journal of Clinical Oncology.
2003
Academic Article
GET IT
Times cited: 57